Bowtie and Scarf Monday
Tie One On for the Cause
This Week's Cause: Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society (LLS) is at the forefront of the fight to cure cancer. We are the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we’ve invested more than $1.2 billion in groundbreaking research, pioneering many of today’s most innovative approaches. The LLS is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Leukemia, lymphoma, myeloma and myelodysplastic syndromes (MDS) are types of cancer that can affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
Contributions can be made in the office of the Vice President for Student Services (110).
Facts & Statistics
- Approximately every 3 minutes one person in the United States (US) is diagnosed with a blood cancer.
- An estimated combined total of 174,250 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2018.
- New cases of leukemia, lymphoma and myeloma are expected to account for 10 percent of the estimated 1,735,350 new cancer cases diagnosed in the US in 2018.
- Prevalence is the estimated number of people alive on a certain date in a population who previously had a diagnosis of the disease. An estimated 1,345,123 people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma.
- Relative survival compares the survival rate of a person diagnosed with a disease to that of a person without the disease. The most recent survival data available may not fully represent the outcomes of all current therapies and, as a result, may underestimate survival to a small degree.